KLRK1 and familial pancreatic carcinoma: There was no statistically significant difference in the expression level of NKG2D in gastric cancer (STAD), cholangiocarcinoma (CHOL), and pancreatic cancer (PAAD) compared with the corresponding normal tissues (Figure 1C).